AstraZeneca’s Imfinzi gets FDA priority review for small cell lung cancer
The company said the FDA accepted its supplemental application and granted priority review to Imfinzi for the treatment of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.